Curtiss-Wright Corporation continues to benefit from strong aerospace, defense, and nuclear energy market tailwinds, driving robust sales and margin growth. CW raised its full-year 2025 guidance, now expecting 9-10% sales growth, 15-18% operating income growth, and improved free cash flow outlook. Despite a significant rally and fair 2026 valuation, CW offers 13% upside when considering 2027 earnings, supported by strong EBITDA and cash flow growth.
Reiterate a buy rating on Bitcoin, citing renewed perspectives with new ETFs. The on-chain metrics studied also seem like a great combination to take Bitcoin to a new ATH. Despite modest September gains, BTC is decoupling from traditional assets, offering portfolio diversification and risk management benefits. Maintain a $138,000 target price for BTC by the end of 2025, supported by strong seasonality and expanding institutional participation, while noting risks from large holder sell-offs.
Target (TGT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
The S&P 500 index (^GSPC 0.59%) is hovering near all-time highs. And yet shares of retailer Target (TGT 1.02%) have lost 66% of their value.
The Travelers Companies remains a "Buy," with shares undervalued and technicals signaling a potential breakout ahead of Q3 earnings. TRV delivered strong Q2 results, including a significant EPS beat, improved combined ratio, and robust shareholder returns via dividends and buybacks. Sell-side sentiment is positive for TRV, with 21 EPS upgrades in the past 90 days and no downgrades, supporting an optimistic earnings outlook.
Target posts mixed results in the fiscal second quarter as tariffs and cautious shoppers cut into margins, even as store traffic and digital demand improved.
Target (TGT 0.55%) continues to struggle to win over investors. Business and political challenges have weighed on the stock.
AMC Networks offers deep value, trading at a steep discount to cash holdings and sector peers, with strong free cash flow and manageable debt until 2029. AMCX's $866 million cash cushion and $250 million in annual FCF supports liquidity, reducing near-term risks. Short sellers may be off the mark. The stock is a potential takeover target in my opinion, with low enterprise valuations and robust gross profit margins making it the most attractive asset in the entertainment sector.
Thermo Fisher unveils the Olink Target 48 Neurodegeneration panel to accelerate biomarker research in neurodegenerative diseases.
TGT's FUN 101 approach lifts Hardlines comps 5%, with trading cards and gaming fueling momentum for a wider merchandising revival.
TOL faces softer demand, but pricing power and efficiency gains can help sustain its 2025 EPS target.
Target (NYSE: TGT) has already decreased approximately 40% over the past year. This decline is painful, yet not entirely unexpected.